Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Leonard

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Endocrinology|January 19, 2008
A role for intestinal endocrine cell-expressed g protein-coupled receptor 119 in glycemic control by enhancing glucagon-like Peptide-1 and glucose-dependent insulinotropic Peptide releaseZhi-Liang Chu, Chris Carroll, Jean Alfonso, et al.
Applied Optics|October 3, 2013
Field trial of active remote sensing using a high-power short-wave infrared supercontinuum laserVinay V Alexander, Zhennan Shi, Mohammed N Islam, et al.
Molecular Endocrinology (Baltimore, Md.)|November 11, 2009
N-oleoyldopamine enhances glucose homeostasis through the activation of GPR119Zhi-Liang Chu, Chris Carroll, Ruoping Chen, et al.
Bioorganic & Medicinal Chemistry Letters|April 2, 2018
Erratum to "Discovery of N-arylpyrroles as agonists of GPR120 for the treatment of type II diabetes" Bioorg. Med. Chem. Lett. 28 (2018) [841-846]Michael P Winters, Zhihua Sui, Mark Wall, et al.
Bioorganic & Medicinal Chemistry Letters|February 20, 2018
Discovery of N-arylpyrroles as agonists of GPR120 for the treatment of type II diabetesMichael P Winters, Zhihua Sui, Mark Wall, et al.
Endocrinology|February 10, 2007
A role for beta-cell-expressed G protein-coupled receptor 119 in glycemic control by enhancing glucose-dependent insulin releaseZhi-Liang Chu, Robert M Jones, Hongmei He, et al.
Journal of Medicinal Chemistry|October 20, 2018
6-Benzhydryl-4-amino-quinolin-2-ones as Potent Cannabinoid Type 1 (CB<sub>1</sub>) Receptor Inverse Agonists and Chemical Modifications for Peripheral SelectivityYue-Mei Zhang, Michael N Greco, Mark J Macielag, et al.
American Journal of Human Genetics|January 21, 2004
Ethylmalonic encephalopathy is caused by mutations in ETHE1, a gene encoding a mitochondrial matrix proteinValeria Tiranti, Pio D'Adamo, Egill Briem, et al.
Bioorganic & Medicinal Chemistry Letters|June 24, 2017
Design, synthesis and SAR of a novel series of heterocyclic phenylpropanoic acids as GPR120 agonistsXuqing Zhang, Chaozhong Cai, Michael Winters, et al.
Journal of Medicinal Chemistry|August 14, 2008
Discovery of the first potent and orally efficacious agonist of the orphan G-protein coupled receptor 119Graeme Semple, Beatriz Fioravanti, Guillherme Pereira, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Endocrinology|January 19, 2008
A role for intestinal endocrine cell-expressed g protein-coupled receptor 119 in glycemic control by enhancing glucagon-like Peptide-1 and glucose-dependent insulinotropic Peptide releaseZhi-Liang Chu, Chris Carroll, Jean Alfonso, et al.
Applied Optics|October 3, 2013
Field trial of active remote sensing using a high-power short-wave infrared supercontinuum laserVinay V Alexander, Zhennan Shi, Mohammed N Islam, et al.
Molecular Endocrinology (Baltimore, Md.)|November 11, 2009
N-oleoyldopamine enhances glucose homeostasis through the activation of GPR119Zhi-Liang Chu, Chris Carroll, Ruoping Chen, et al.
Bioorganic & Medicinal Chemistry Letters|April 2, 2018
Erratum to "Discovery of N-arylpyrroles as agonists of GPR120 for the treatment of type II diabetes" Bioorg. Med. Chem. Lett. 28 (2018) [841-846]Michael P Winters, Zhihua Sui, Mark Wall, et al.
Bioorganic & Medicinal Chemistry Letters|February 20, 2018
Discovery of N-arylpyrroles as agonists of GPR120 for the treatment of type II diabetesMichael P Winters, Zhihua Sui, Mark Wall, et al.
Endocrinology|February 10, 2007
A role for beta-cell-expressed G protein-coupled receptor 119 in glycemic control by enhancing glucose-dependent insulin releaseZhi-Liang Chu, Robert M Jones, Hongmei He, et al.
Journal of Medicinal Chemistry|October 20, 2018
6-Benzhydryl-4-amino-quinolin-2-ones as Potent Cannabinoid Type 1 (CB<sub>1</sub>) Receptor Inverse Agonists and Chemical Modifications for Peripheral SelectivityYue-Mei Zhang, Michael N Greco, Mark J Macielag, et al.
American Journal of Human Genetics|January 21, 2004
Ethylmalonic encephalopathy is caused by mutations in ETHE1, a gene encoding a mitochondrial matrix proteinValeria Tiranti, Pio D'Adamo, Egill Briem, et al.
Bioorganic & Medicinal Chemistry Letters|June 24, 2017
Design, synthesis and SAR of a novel series of heterocyclic phenylpropanoic acids as GPR120 agonistsXuqing Zhang, Chaozhong Cai, Michael Winters, et al.
Journal of Medicinal Chemistry|August 14, 2008
Discovery of the first potent and orally efficacious agonist of the orphan G-protein coupled receptor 119Graeme Semple, Beatriz Fioravanti, Guillherme Pereira, et al.
Pageof 6